Atherosclerosis Plus : Impact Factor & More
eISSN: 2667-0895pISSN: 2667-0909
Open AccessShare this on:
Key Metrics
CiteScore 
2
Impact Factor
< 5
SNIP
0.42
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Atherosclerosis Plus Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2050 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | European Atherosclerosis Society |
| Frequency | Continuous publication |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Atherosclerosis Plus ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Atherosclerosis Plus
Neural Network Model Outperforms Conventional Equations in LDL Cholesterol Estimation: A Comparative Study of 188,887 Chinese Individuals with Focus on Hypertriglyceridemia
- 1 Nov 2025
- Atherosclerosis Plus
Layered Plaque in Patients with Chronic Coronary Syndrome
- 1 Nov 2025
- Atherosclerosis Plus
Earthworm fibrinolytic enzyme A and fibrin-derived peptide Bβ15-42 attenuate atherosclerosis via the VE-Cadherin signaling pathway
- 30 Oct 2025
- Atherosclerosis Plus
Midlife ICAM-1 levels may predict cardiovascular disease and cognitive decline in latelife: Insights from the HeartSCORE study
- 14 Oct 2025
- Atherosclerosis Plus
Inclisiran for fast-track lipid-lowering treatment early after an acute coronary syndrome: a pilot study
- 24 Sep 2025
- Atherosclerosis Plus
Demographic and regional trends of mortality in patients with cardiovascular disease and liver cirrhosis in the United States between 1999 and 2019
- 20 Sep 2025
- Atherosclerosis Plus
Neural Network Model Outperforms Conventional Equations in LDL Cholesterol Estimation: A Comparative Study of 188,887 Chinese Individuals with Focus on Hypertriglyceridemia
- 1 Nov 2025
- Atherosclerosis Plus
Layered Plaque in Patients with Chronic Coronary Syndrome
- 1 Nov 2025
- Atherosclerosis Plus
Earthworm fibrinolytic enzyme A and fibrin-derived peptide Bβ15-42 attenuate atherosclerosis via the VE-Cadherin signaling pathway
- 30 Oct 2025
- Atherosclerosis Plus
Midlife ICAM-1 levels may predict cardiovascular disease and cognitive decline in latelife: Insights from the HeartSCORE study
- 14 Oct 2025
- Atherosclerosis Plus
Inclisiran for fast-track lipid-lowering treatment early after an acute coronary syndrome: a pilot study
- 24 Sep 2025
- Atherosclerosis Plus
Demographic and regional trends of mortality in patients with cardiovascular disease and liver cirrhosis in the United States between 1999 and 2019
- 20 Sep 2025
- Atherosclerosis Plus
FAQs on Atherosclerosis Plus
What is the publishing frequency of Atherosclerosis Plus? 
How many articles did Atherosclerosis Plus publish last year?
What is the eISSN & pISSN for Atherosclerosis Plus?
What is Citescore for Atherosclerosis Plus?
What is SNIP score for Atherosclerosis Plus?
Who is the publisher of Atherosclerosis Plus?
